Haixia Q. Su
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease Inhibitors.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 04, 2025
Development of Orally Bioavailable Octahydroindole-Based Peptidomimetic Derivative as a Broad-Spectrum Inhibitor against HCoV-OC43 and SARS-CoV-2.
Journal: Journal of medicinal chemistry
Published: May 22, 2025
Identification of RIPK3 as a target of flavonoids for anti-necroptosis in vitro.
Journal: Bioorganic chemistry
Published: February 15, 2025
Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 25, 2025
Potency Prediction of Covalent Inhibitors against SARS-CoV-2 3CL-like Protease and Multiple Mutants by Multiscale Simulations.
Journal: Journal of chemical information and modeling
Published: November 28, 2024
De novo design of protein condensation inhibitors by targeting an allosteric site of cGAS.
Journal: Nature communications
Published: September 20, 2024
Discovery of Novel Nonpeptidic and Noncovalent Small Molecule 3CLpro Inhibitors as anti-SARS-CoV-2 Drug Candidate.
Journal: Journal of medicinal chemistry
Published: July 29, 2024
Correction: Discovery of novel non-peptidic and non-covalent small-molecule 3CLpro inhibitors as potential candidate for COVID-19 treatment.
Journal: Signal transduction and targeted therapy
Published: October 13, 2023
Structure-based design of potent FABP4 inhibitors with high selectivity against FABP3.
Journal: European journal of medicinal chemistry
Published: October 07, 2023
Drug repurposing and structure-based discovery of new PDE4 and PDE5 inhibitors.
Journal: European journal of medicinal chemistry
Published: September 10, 2023
Last Updated: 09/26/2026